We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Environmental microplastics and liver health: Brief review on human exposure and accumulation, hepatotoxicity mechanism, and intervention strategies
Summary
Tiny plastic particles that get into our bodies from food, water, and air may build up in the liver and contribute to problems like fatty liver disease, scarring, and possibly liver cancer, according to this review of existing lab, animal, and human research. Scientists still don't have solid proof this happens in real-world amounts of exposure in people—most evidence so far comes from cells and animals given high doses—but the patterns are concerning enough that researchers are calling for more human studies and are already exploring ways to help the body clear out these particles. Bottom line: we don't yet know exactly how risky everyday plastic exposure is for your liver,
Environmental microplastics (MPs) are ubiquitous contaminants arising from the weathering and disposal of widely used polymers. Increasing experimental and emerging clinical data implicate MPs in a spectrum of liver disorders, including fibrosis, non-alcoholic fatty liver disease (NAFLD), cholestatic liver disease (CLD), and potentially hepatocellular carcinoma (HCC). Unlike previous reviews that often discuss MPs exposure, toxicological mechanisms, or analytical/detection methods in isolation, this review proposes a comprehensive, integrative framework that links human exposure pathways, hepatic accumulation and clearance, toxicity mechanisms, and potential interventions. This framework systematically synthesizes mechanistic evidence from in vitro , animal, and organoid studies, encompassing oxidative stress, inflammation, metabolic reprogramming, and regulated cell death (e.g., ferroptosis and apoptosis). It also provides an in-depth discussion of diverse intervention strategies targeting gut-liver translocation, hepatic clearance, and downstream pathological processes. Although numerous studies demonstrate plausible biological mechanisms, human epidemiological data remain sparse and largely cross-sectional; only limited clinical samples have confirmed the presence of intrahepatic MPs, and causal inference at environmental exposure levels is unresolved. We identify critical knowledge gaps, including the overreliance on polystyrene model particles and the inadequate assessment of the "carrier effect" through which MPs enhance the bioavailability and hepatic accumulation of co-adsorbed pollutants, and consequently propose research priorities that emphasize environmentally relevant exposure paradigms, broader polymer physicochemical properties, and longitudinal cohort studies. This comprehensive approach enables this review to serve as a reference for future experimental design, clinical research, and the formulation of evidence-based policies for protecting liver health.